Main

related bits

0

processing priority

4

site type

0 (generic, awaiting analysis)

review version

11

html import

20 (imported)

Events

first seen date

2024-02-04 09:29:32

expired found date

-

created at

2024-06-10 17:40:15

updated at

2026-01-04 23:52:58

Domain name statistics

length

12

crc

32706

tld

2211

nm parts

0

nm random digits

0

nm rare letters

0

Connections

is subdomain of id

-

previous id

0

replaced with id

0

related id

-

dns primary id

7821347

dns alternative id

0

lifecycle status

0 (unclassified, or currently active)

Subdomains and pages

deleted subdomains

0

page imported products

0

page imported random

0

page imported parking

0

Error counters

count skipped due to recent timeouts on the same server IP

0

count content received but rejected due to 11-799

0

count dns errors

0

count cert errors

0

count timeouts

0

count http 429

0

count http 404

0

count http 403

0

count http 5xx

0

next operation date

-

Server

server bits

server ip

-

Mainpage statistics

mp import status

20

mp rejected date

-

mp saved date

-

mp size orig

12890

mp size raw text

2484

mp inner links count

2

mp inner links status

20 (imported)

Open Graph

title

description

ECMH: The first pro-healing, non-surgical treatment option for patients suffering from Inflammatory Bowel Diseases.

site name

author

updated

2025-12-23 02:40:50

raw text

Regentys - Regentys Toggle navigation Menu About Leadership Board of Directors Medical Advisory Board Frequently Asked Questions A Father's Mission The Disease Research Collaborations McGowan Institute For Patients Press Contact ExtraCellular Matrix Hydrogel (ECMH) The first non-surgical treatment option for Ulcerative Colitis REGENTYS ™ is a development stage, regenerative medicine company focused on developing treatments for patients with gastrointestinal (GI) disorders. Our first product, ExtraCellular Matrix Hydrogel (ECMH) , is a first-in-class, non-pharmacologic, non-surgical treatment option for patients suffering from Ulcerative Colitis .  Generex Biotechnology Partner Regentys Corporation Receives European Patent Approval for ECMH™ for Treatment of Ulcerative Colitis Dec. 14, 2018 — Generex Biotechnology Corporation (OTCQB:GNBT) announced today that Regentys Corporation (formerly Asana Medical, Inc.), a clinical stage rege...

Text analysis

redirect type

0 (-)

block type

0 (no issues)

detected language

1 (English)

category id

Nowotwory (78)

index version

2025123101

spam phrases

0

Text statistics

text nonlatin

0

text cyrillic

0

text characters

1976

text words

323

text unique words

179

text lines

53

text sentences

11

text paragraphs

4

text words per sentence

29

text matched phrases

1

text matched dictionaries

2

RSS

rss path

rss status

1 (priority 1 already searched, no matches found)

rss found date

-

rss size orig

0

rss items

0

rss spam phrases

0

rss detected language

0 (awaiting analysis)

inbefore feed id

-

inbefore status

0 (new)

Sitemap

sitemap path

sitemap status

1 (priority 1 already searched, no matches found)

sitemap review version

1

sitemap urls count

0

sitemap urls adult

0

sitemap filtered products

0

sitemap filtered videos

0

sitemap found date

-

sitemap process date

2024-06-29 03:19:42

sitemap first import date

-

sitemap last import date

-